A new grant from the American Cancer Society (ACS) will fund research into a new strategy for targeting glioblastoma at MUSC ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

Ultomiris is a brand-name biologic medication prescribed for certain rare autoimmune disorders. Dosing of Ultomiris is done via intravenous (IV) infusions administered by a healthcare professional.

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, ...

NAB believes that with GPS increasingly recognized as a potential single point of failure, BPS has an important role to play.

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada ...

California's largest state park expansion in decades would bring the total to 283 parks, far more than any other state.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," ...

Does Credo Technology Group Holding Ltd. (CRDO) have what it takes to be a top stock pick for momentum investors? Let's find out.